Skip to main content
Livermore
Livermore
ZHEN

D. E. Shaw & Co., Inc.

SEC CIK
0001009207
Latest filing
Aug 14, 2026

DXCM holding history

Dexcom Inc in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

DXCM overviewAll 13F holders of DXCMFull Q2 2026 holdings

Shares (Q2 2026)
5,679
Value
$382.5K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of DXCM by D. E. Shaw & Co., Inc., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20265,679$382.5K<0.1%−22,053−79.5%ReducedHolders
Q1 202627,732$1.74M<0.1%−3,910,836−99.3%ReducedHolders
Q4 20253,938,568$261.4M0.2%+1,735,081+78.7%AddedHolders
Q3 20252,203,487$148.3M0.1%+241,897+12.3%AddedHolders
Q2 20251,961,590$171.2M0.2%−1,120,179−36.3%ReducedHolders
Q1 20253,081,769$210.5M0.2%−448,364−12.7%ReducedHolders
Q4 20243,530,133$274.5M0.3%+1,100,610+45.3%AddedHolders
Q3 20242,429,523$162.9M0.2%+2,393,783+6,697.8%AddedHolders
Q2 202435,740$4.05M<0.1%−495,211−93.3%ReducedHolders
Q1 2024530,951$73.6M0.1%+404,440+319.7%AddedHolders
Q4 2023126,511$15.7M<0.1%−35,617−22.0%ReducedHolders
Q3 2023162,128$15.1M<0.1%−120,448−42.6%ReducedHolders
Q2 2023282,576$36.3M0.1%+124,523+78.8%AddedHolders
Q1 2023158,053$18.4M<0.1%+98,408+165.0%AddedHolders
Q4 202259,645$6.75M<0.1%+55,884+1,485.9%AddedHolders
Q3 20223,761$303.0K<0.1%+103+2.8%AddedHolders
Q2 20223,658$273.0K<0.1%−24,558−87.0%ReducedConverted for a 4-for-1 splitHolders
Q1 20227,054$3.61M<0.1%−9,658−57.8%ReducedHolders
Q4 202116,712$8.97M<0.1%−33,006−66.4%ReducedHolders
Q3 202149,718$27.2M<0.1%+17,354+53.6%AddedHolders
Q2 202132,364$13.8M<0.1%+9,147+39.4%AddedHolders
Q1 202123,217$8.34M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.